147084-10-4 | Alcaftadine

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$14.00	$10.00
5mg	95%	in stock	$37.00	$26.00
10mg	98%	in stock	$48.00	$34.00
25mg	98%	in stock	$81.00	$57.00
100mg	95%	in stock	$292.00	$205.00
1g	98%	in stock	$1,307.00	$915.00

Description

• Catalog Number: AV19869
• Chemical Name: Alcaftadine
• CAS Number: 147084-10-4
• Molecular Formula: C19H21N3O
• Molecular Weight: 307.3895
• MDL Number: MFCD09954106
• SMILES: O=Cc1cnc2n1CCc1c(C2=C2CCN(CC2)C)cccc1

Computed Properties

• Complexity: 479
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 23
• Hydrogen Bond Acceptor Count: 3
• Rotatable Bond Count: 1
• XLogP3: 1.7

Literature

• New drugs 2012 part I.

  Nursing 20120301

• Alcaftadine for the prevention of itching associated with allergic conjunctivitis.

  The Annals of pharmacotherapy 20120101

• Histamine and H1-antihistamines: celebrating a century of progress.

  The Journal of allergy and clinical immunology 20111201

• Alcaftadine: a topical antihistamine for use in allergic conjunctivitis.

  Drugs of today (Barcelona, Spain : 1998) 20111201

• Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110401

• Alcaftadine (Lastacaft) for allergic conjunctivitis.

  The Medical letter on drugs and therapeutics 20110307

• The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis.

  Current medical research and opinion 20110301

• Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis.

  Drug design, development and therapy 20110101

• Vilazodone hydrochloride, linagliptin, and alcaftadine.

  Journal of the American Pharmacists Association : JAPhA 20110101